
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers
NutritionInsight spoke with Kelsey Achenbach of Roquette at CPhI 2018 in Madrid about the company's portfolio expansion in biopharmaceuticals. This year, Roquette’s featured products included the newly launched low endotoxin Kleptose BioPharma HPB/HP grades of hydroxypropyl β-cyclodextrins for protein stability, as well as Dextrose Anhydrous BioPharma for cell culture solutions.
Upcoming webinars

Bifidobacteria and Healthy Ageing: New Insights into Ageing and Immunity
Morinaga
Register now

The future of infant nutrition: From science to success
Valio
Register now

From tiny guts to big impact: the powerful potential of probiotics in children’s health
Novonesis
Register now
All upcoming webinars
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement
















